Samjin Pharmaceutical Co., Ltd.

About Samjin Pharmaceutical Co., Ltd.

We, Samjin Pharmaceutical Co., Ltd. are striving to develop a drug for a healthy life and fruitful future as one of the leading companies in Korea. Since our company was founded in 1968, we have been growing up with competitive medical products and a high preference for patients. And also our R&D Center is strengthening its global competitiveness by getting an outstanding pipeline.




...

Certifications
  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
API Producer
Pharmaceutical Company (generic finished products)
Contact info
  • 121, Wausan-ro, Mapo-gu, 04054, Seoul, Korea, Republic Of

Products from Samjin Pharmaceutical Co., Ltd. (3)

  • Clopidogrel Tablet

    Product Clopidogrel Tablet

    Indication: Antiplatelet API: Clopidogrel Bisulfate 75mg BE data: Available CTD: Available Export: Philippines, Singapore.
  • Letrozole Tablet

    Product Letrozole Tablet

    Oncology Indication: Postmenopausal hormone receptor-positive breast cancer API: Letrozole 2.5mg BE data: Available CTD: Available
  • Maciten Tablet

    Product Maciten Tablet

    1. Active Ingredient & Strength : Micronized Macitentan 10 mg 2. Indication : Pulmonary arterial hypertension (PAH) 3. Characteristics : - Dual ERA (bosentan + ambrisentan) - Long-term treatment of adult patients with PAH (WHO Group I) corresponding to WHO functional classifications II to III 4. Developm...

Samjin Pharmaceutical Co., Ltd. Resources (1)